Edap TMS SA recently published data showing that its Focal One high intensity focused ultrasound technology is non-inferior to radical prostatectomy as a first-line treatment for localized prostate ...

Semi-Live Focal One Procedure to be Conducted on August 15 t h at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today ...

AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial ...

AUSTIN, Texas, March 27, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited consolidated financial results for the fourth quarter and full ...

EDAP TMS SA announced the successful treatment of the first patient in its phase I/II PULS Trial, which is investigating the use of High Intensity Focused Ultrasound (HIFU) technology for pancreatic ...

John Wayne Cancer Institute (JWCI) at Providence Saint John’s Health Center is once again breaking new ground to benefit cancer patients. It has become the first medical center in the country to ...

LYON, France, August 6, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the Company’s leading robotic HIFU technology platform, Focal One, will be ...